Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio-Reference-Cited by-同舟云学术

Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio

Published:2014-07-23 Issue:5 Volume:136 Page:1234-1240
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ferroni Patrizia¹,Riondino Silvia²,Formica Vincenzo²,Cereda Vittore²,Tosetto Livia²,La Farina Francesca³,Valente Maria Giovanna³,Vergati Matteo²,Guadagni Fiorella¹,Roselli Mario²

Affiliation:

1. Biomarker Discovery and Advanced Biotechnology (BioDAT) Laboratory; IRCCS San Raffaele Pisana, Research Center; Rome Italy

2. Department of Systems Medicine, Medical Oncology, Tor Vergata Clinical Center; University of Rome “Tor Vergata”; Rome Italy

3. San Raffaele Foundation; Ceglie Messapica Hospital; Ceglie Messapica Italy

Funder

Italian Ministry of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States;Khorana;Cancer,2013

2. Virchow's triad revisited: abnormal flow;Lowe;Pathophysiol Haemost Thromb,2003

3. Cancer-related inflammation: common themes and therapeutic opportunities;Balkwill;Semin Cancer Biol,2012

4. Cancer-related inflammation;Candido;J Clin Immunol,2013

5. Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans;Rak;Cancer Res,2006

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in retinal artery occlusion: a meta-analysis;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-08-14

2. Circulating Blood Biomarkers and Risk of Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis;Thrombosis and Haemostasis;2024-05-20

3. Machine Learning-Based Clinical Risk Model for Predicting Thromboembolism After First-Line Immunotherapy in Lung Cancer Patients;2024

4. Research Progress on Risk Factors and Risk Assessment Models for VTE in Malignant Tumor Patients;Advances in Clinical Medicine;2024

5. Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer;Seminars in Thrombosis and Hemostasis;2023-12-04